Inspire Medical Systems (INSP) Tops Q2 EPS by 38c, Beats on Revenue; Offers FY26 Revenue Guidance

Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of $0.14, $0.38 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $200.6 million versus the consensus estimate of $194.67 million.

GUIDANCE:

Inspire Medical Systems sees FY2026 revenue of $835-875 million, versus the consensus of $843 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Berenberg Upgrades Clariant AG (CLN:SW) (CLZNY) to Buy
• Deutsche Bank Downgrades AtaiBeckley Inc (ATAI) to Hold